Effects of nitric oxide synthase inhibition on glutamine action in a bacterial translocation model

British Journal of Nutrition

Volumn 111, Issue 1, 2014, Pages 93-100

  Santos, Rosana G C ^a   Quirino, Iara E P ^a   Viana, Mirelle L ^a   Generoso, Simone V ^a   Nicoli, Jacques R ^a   Martins, Flaviano S ^a   Nogueira Machado, José A ^b   Arantes, Rosa M E ^a   Correia, Maria I T D ^a   Cardoso, Valbert N ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Instituto de Ensino   (Brazil)

Author keywords

99mTechnetium; Bacterial translocation; Glutamine; Nitric oxide

Indexed keywords

GAMMA INTERFERON; GLUTAMINE; INTERLEUKIN 10; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PENTETATE IRON TECHNETIUM TC 99M; SECRETORY IMMUNOGLOBULIN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HISTOLOGY; ILEUM; IMMUNE RESPONSE; INTESTINE FLUID; INTESTINE MUCOSA PERMEABILITY; INTESTINE OBSTRUCTION; LIGATION; MALE; MOUSE; NONHUMAN; RADIOACTIVITY;

ANIMALS; BACTERIAL TRANSLOCATION; ENZYME INHIBITORS; ESCHERICHIA COLI; GLUTAMINE; ILEUM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; LIGATION; MALE; MICE; MICE, INBRED STRAINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTETIC ACID; PERMEABILITY; SIGNAL TRANSDUCTION;

EID: 84891795291     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001888     Document Type: Article

References (51)

1. Zheng YM, Li F, Zhang MM, et al. (2006) Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. World J Gastroenterol 12, 7537-7541.
2. Rhoads JM, Argenzio RA, Chen W, et al. (1997) L-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 272, 943-953.
3. Curi R, Lagranha CJ, Doi SQ, et al. (2005) Molecular mechanisms of glutamine action. J Cell Physiol 204, 392-401.
4. Carr EL, Kelman A, Wu GS, et al. (2010) Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol 185, 1037-1044.
5. Wiest R & Rath HC (2003) Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17, 397-425.
6. Zanoni FL, Benabou S, Greco KV, et al. (2009) Mesenteric microcirculatory dysfunctions and translocation of indigenous bacteria in a rat model of strangulated small bowel obstruction. Clinics 64, 911-919.
7. Shiomi H, Shimizu T, Endo Y, et al. (2007) Relations among circulating monocytes, dendritic cells, and bacterial translo-cation in patients with intestinal obstruction. World J Surg 31, 1806-1812.
8. Lotz M, König T, Ménard S, et al. (2007) Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 122, 306-315.
9. Amin PB, Diebel LN & Liberati DM (2008) Secretory immunoglobulin A blunts gut-mediated priming of neutro-phils in vitro. J Trauma 64, 1437-1442.
10. Sanjabi S, Zenewicz LA, Kamanaka M, et al. (2009) Anti-inflammatory and pro-inflammatory roles of TGF-b, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9, 447-453.
11. Ding LA & Li JS (2003) Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia. World J Gastroenterol 9, 1327-1332.
12. Wu G & Meininger CJ (2002) Regulation of nitric oxide synthesis by dietary factors. Annu Rev Nutr 22, 61-86.
13. Barocelli E, Ballabeni V, Ghizzardi P, et al. (2006) The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide 14, 212-218.
14. Aktan F (2004) iNOS mediated nitric oxide production and its regulation. Life Sci 75, 639-653.
15. Kubes P (2000) Inducible nitric oxide synthase: a little bit of good in all of us. Gut 47, 6-9.
16. Naito Y, Takagi T, Ichikawa H, et al. (2004) A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats. Nitric Oxide 10, 170-177.
17. de Oliveira MA, Lemos DS, Diniz SO, et al. (2006) Prevention of bacterial translocation using glutamine: a new strategy of investigation. Nutrition 22, 419-424.
18. dos Santos RG, Viana ML, Generoso SV, et al. (2010) Gluta-mine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model. J Parenter Enteral Nutr 34, 408-413.
19. Salvalaggio PR, Neto CZ, Tolazzi AR, et al. (2002) Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread. Nutrition 18, 334-337.
20. Quirino IE, Correia MI & Cardoso VN (2007) The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr 26, 335-340.
21. 99mTechne-tium labelled Escherichia coli. Appl Radiat Isot 51, 33-36.
22. Viana ML, Santos RG, Generoso SV, et al. (2010) Pretreat-ment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26, 218-223.
23. Generoso SV, Viana M, Santos R, et al. (2010) Saccharomyces cerevisiae strain UFMG 905 protects against bacterial trans-location, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192, 477-484.
24. Generoso SV, Viana ML, Santos RG, et al. (2011) Protection against increased intestinal permeability and bacterial trans-location induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 50, 261-269.
25. Martins FS, Silva AA, Vieira AT, et al. (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191, 623-630.
26. Rodrigues AC, Cara DC, Fretez SH, et al. (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89, 404-414.
27. van de Poll MC, Ligthart-Melis GC, Boelens PG, et al. (2007) Intestinal and hepatic metabolism of glutamine and citrulline in humans. J Physiol 581, 819-827.
28. Han X, Fink MP & Delude R (2003) Proinflammatory cytokines cause NO*-dependent and-independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19, 229-237.
29. Wang Q & Hasselgren PO (2002) Heat shock response reduces intestinal permeability in septic mice: potential role of interleukin-10. Am J Physiol Regul Integr Comp Physiol 282, 669-676.
30. Wischmeyer PE, Musch MW, Madonna MB, et al. (1997) Glutamine protects intestinal epithelial cells: role of indu-cible HSP70. Am J Physiol 272, 879-884.
31. Musch MW, Hayden D, Sugi K, et al. (1998) Cell-specific induction of hsp72-mediated protection by glutamine against oxidant injury in IEC18 cells. Proc Assoc Am Physicians 110, 136-139.
32. Perricone C, Carolis C & Perricone R (2009) Glutathione: a key player in autoimmunity. Autoimmun Rev 8, 697-701.
33. Zhou X, Wu X, Yin Y, et al. (2012) Preventive oral supplementation with glutamine and arginine has beneficial effects on the intestinal mucosa and inflammatory cytokines in endotoxemic rats. Amino Acids 43, 813-821.
34. Ban K & Kozar RA (2010) Glutamine protects against apop-tosis via downregulation of Sp3 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 299, 1344-1353.
35. Yeh CL, Hsu CS, Yeh SL, et al. (2005) Dietary glutamine supplementation modulates Th1/Th2 cytokine and interleukin-6 expressions in septic mice. Cytokine 31, 329-334.
36. Horio Y, Osawa S, Takagaki K, et al. (2008) Glutamine supplementation increases Th1-cytokine responses in murine intestinal intraepithelial lymphocytes. Cytokine 44, 92-95.
37. Dinarello CA (2000) Proinflammatory cytokines. Chest 118, 503-508.
38. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
39. Naderibeni F, Fattahi F, Mirshafiey A, et al. (2012) Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment. Int Immunopharmacol 12, 689-693.
40. MacFie J (2004) Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull 71, 1-11.
41. Boelens PG, Houdijk AP, Fonk JC, et al. (2004) Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical study. Clin Nutr 23, 391-400.
42. Oliveira GP, Oliveira MB, Santos RS, et al. (2009) Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit Care 13, R74.
43. Wang Q, Fang CH & Hasselgren PO (2001) Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281, R1013-R1023.
44. Redpath S, Ghazal P & Gascoigne NR (2001) Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 9, 86-92.
45. Kudsk KA (2008) Glutamine: more evidence, more promise. J Parenter Enteral Nutr 32, 492-494.
46. Kudsk KA, Wu Y, Fukatsu K, et al. (2000) Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. J Parenter Enteral Nutr 24, 270-275.
47. Fukatsu K, Kudsk KA, Zarzaur BL, et al. (2001) TPN decreases IL-4 and IL-10 mRNA expression in lipopoly-saccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression. Shock 15, 318-322.
48. Jiang JW, Ren ZG, Chen LY, et al. (2011) Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int 10, 380-385.
49. Akaike T, Okamoto T, Zaki MH, et al. (2009) New paradigm of host defense against intracellular pathogens by nitric oxide. Nihon Hansenbyo Gakkai Zasshi 78, 41-47.
50. Abreu MT, Palladino AA, Arnold ET, et al. (2000) Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology 119, 1524-1536.
51. Arrieta MC, Bistritz L & Meddings JB (2006) Alterations in intestinal permeability. Gut 55, 1512-1520.